April 8, 2026
In Performance Year 2024, 476 MSSP ACOs collectively earned $4.1 billion in shared savings. That number sounds impressive until you realize how much they left behind. U.S. healthcare organizations lose more than $262 billion annually to revenue cycle inefficiency, and ACOs—with their multi-practice, multi-EHR complexity—are disproportionately exposed.
Here is the uncomfortable truth: most ACOs treat revenue cycle management (RCM) as a back-office function. They invest in care coordination, quality reporting, and population health dashboards. Meanwhile, 19.1% of in-network claims are denied on first submission, and 65% of those denied claims are never corrected and resubmitted, according to the American Medical Association. That is not a billing problem. That is a structural leak in your shared savings model.
Fee-for-service practices have denial problems. ACOs have denial compounding problems. Here is why:
A typical MSSP ACO includes 50-200+ participating providers across primary care, specialty, and post-acute settings. Each practice may run a different EHR, use different billing workflows, and have different coding accuracy baselines. When you aggregate claims across that network, denial root causes become nearly impossible to diagnose manually.
Starting in PY 2026, CMS is moving Standard ACOs to a 60/40 historical-to-regional blend for benchmarks. That means your own past expenditure data carries more weight. If denied claims lead to delayed or lost reimbursement—and your expenditure data looks artificially low as a result—your future benchmarks tighten. You are punished twice: once on the revenue you never collected, and again on the benchmark that assumes you never needed it.
CMS is also implementing new caps on early-year risk score growth in PY 2026 to curb aggressive coding. For ACOs that are under-coding because claims keep getting denied and reworked, this creates a perverse incentive trap. Your risk adjustment does not reflect the true acuity of your population, your benchmark is lower, and your shared savings shrink.
The numbers are stark and getting worse for organizations that have not invested in automation:
For ACOs specifically, the problem concentrates in three areas: prior authorization failures (especially as WISeR adds new PA requirements in six states), specialist referral claim mismatches, and post-acute care billing errors where the ACO has the least operational control.
The term "AI in revenue cycle" has been thrown around since 2019. Most of what shipped was rules-based automation with a machine learning label. The shift happening in 2026 is fundamentally different: agentic AI systems that can reason through multi-step revenue processes without human intervention.
Here is what that means in practice:
An agentic AI system does not just flag a claim that is missing a modifier. It identifies the missing documentation, retrieves the correct clinical note from the EHR, validates it against payer-specific rules, cross-references the patient's coverage and authorization status, and corrects the claim—all before it hits the clearinghouse. McKinsey's recent analysis describes this as the "race to a touchless revenue cycle," and the ACOs that get there first will have a structural financial advantage.
Every major payer updates their claims editing logic quarterly. UnitedHealthcare, which denied 20% of 6.4 million claims in 2024, has different rules than Aetna, which has different rules than regional Blues plans. An agentic system continuously ingests payer rule changes and adapts submission logic accordingly—no manual update cycles, no lag time where claims slip through with outdated formatting.
This is where agentic AI becomes uniquely powerful for ACOs. When you have 100+ practices submitting claims, an AI agent can identify that Practice A's denial rate for E/M codes spiked 8% last month because of a coding template change, while Practice B's timely filing rate dropped because their clearinghouse integration broke. It surfaces these patterns, assigns root causes, and can even trigger corrective workflows—reassigning claims to a rework queue, alerting practice managers, or adjusting future claim logic automatically.
When denials do occur, agentic AI drafts the appeal, attaches the relevant clinical documentation, matches the appeal to the specific denial reason code, and submits through the correct payer channel. Early adopters are reporting 2.5% reductions in denial rates and nearly $1 million in additional recovered revenue within three months (FinThrive, 2026).
At Zynix, we have seen this problem from the inside. Our CEO, Gautam Chowdhary, spent years as a primary care physician inside ACO networks before building the AI infrastructure that now serves six ACOs managing over $300 million in attributed spend. The pattern was always the same: brilliant clinicians doing transformative care work, undermined by revenue cycle failures that nobody had the bandwidth to fix.
What we have learned across those six ACOs is that denial management cannot be bolted on. It has to be woven into the same data infrastructure that powers your quality reporting, your care coordination, and your risk stratification. Here is why:
If you are an ACO operator reading this, here is where to start:
Pull 90 days of denial data across your full provider network. Categorize by denial reason code, payer, practice, and service type. Most ACOs have never done this at the network level—they have practice-level visibility at best.
For your top five payers by claim volume, document their current prior authorization requirements, claims editing rules, and appeals submission processes. This becomes the knowledge base your AI system will use.
Deploy an agentic AI layer between your EHR/practice management systems and your clearinghouse. This layer validates every claim against payer-specific rules, checks authorization status, flags documentation gaps, and either auto-corrects or routes to human review before submission.
Connect your denial outcomes back to your upstream workflows. Every denial should generate a signal that improves future claim accuracy. Over 90 days, a well-implemented system should reduce your clean claim rate gap by 40-60%.
Let us do the math for a mid-sized ACO with 30,000 attributed beneficiaries and $400M in total cost of care:
Now factor in the benchmark impact. If even 5% of those denials create expenditure reporting anomalies, your shared savings calculation shifts by hundreds of thousands of dollars. For an ACO operating on 2-4% shared savings margins, that is the difference between a distribution check and a loss.
The ROI on agentic AI for denial management is not theoretical. It is the highest-leverage investment most ACOs are not making.
The ACOs that will thrive under CMS's tightening 2026 benchmarks, WISeR prior auth requirements, and new quality measure expansions are the ones that treat revenue cycle as a core competency—not a back-office afterthought. Agentic AI is not a nice-to-have. It is the infrastructure layer that connects your clinical operations to your financial performance.
If your shared savings are leaking through denied claims, you do not have a billing problem. You have an architecture problem. And architecture problems require architecture solutions.